Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer.

W van den Bogaert; E van der Schueren; J C Horiot; G Chaplain; M Devilhena; S Raposo; J Leonor; S Schraub; C Chenal; E Barthelme

doi:10.1016/0360-3016(86)90067-2

Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer.

Identifier:nobleid.org/w1/20260515/ABC5BC08

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/ABC5BC08.svg?ark=w1%2F20260515%2FABC5BC08)](https://nobleid.org/work/w1/20260515/ABC5BC08)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer.

Identifier:nobleid.org/w1/20260515/ABC5BC08

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/ABC5BC08.svg?ark=w1%2F20260515%2FABC5BC08)](https://nobleid.org/work/w1/20260515/ABC5BC08)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work